This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perz, J. F.
Right arrow Articles by Schaffner, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perz, J. F.
Right arrow Articles by Schaffner, W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 2005, p. 5316-5318, Vol. 43, No. 10
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.10.5316-5318.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Pseudomonas putida Septicemia in a Special Care Nursery Due to Contaminated Flush Solutions Prepared in a Hospital Pharmacy

Joseph F. Perz,1* Allen S. Craig,2 Charles W. Stratton,3 Stanley J. Bodner,3 Walter E. Phillips Jr.,4 and William Schaffner2,3

Centers for Disease Control and Prevention, Office of Workforce and Career Development, Epidemic Intelligence Service, State Branch, Atlanta, Georgia,1 Tennessee Department of Health, Communicable and Environmental Disease Services,2 Vanderbilt University School of Medicine, Department of Preventive Medicine,3 Centennial Medical Center, Microbiology Laboratory, Nashville, Tennessee4

Received 1 July 2005/ Accepted 7 July 2005

Pseudomonas putida bloodstream infections were reported in two preterm neonates from a special care nursery. An unopened container of preservative-free heparin flush, compounded several weeks earlier in the hospital pharmacy and from the same batch that was administered to the patients, grew P. putida with a pulsed-field gel electrophoresis (PFGE) pattern identical to that of the patients' isolates. Intrinsic contamination was ruled out by the absence of similar reports from other hospitals and by sterility testing of unopened stock solutions. We investigated the in vitro persistence of P. putida in heparinized saline: even under refrigerated conditions, inocula of 102 and 103 CFU/ml exhibited growth at 21 and 35 days, respectively. These findings highlight the need for compliance with current standards of aseptic technique and quality assurance during the preparation of compounded sterile products.


* Corresponding author. Mailing address: Division of Viral Hepatitis, MS G-37, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, Georgia 30333. Phone: (404) 371-5910. Fax: (404) 371-5221. E-mail: jperz{at}cdc.gov.


Journal of Clinical Microbiology, October 2005, p. 5316-5318, Vol. 43, No. 10
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.10.5316-5318.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Meyer, J.-M., Gruffaz, C., Tulkki, T., Izard, D. (2007). Taxonomic heterogeneity, as shown by siderotyping, of strains primarily identified as Pseudomonas putida. Int. J. Syst. Evol. Microbiol. 57: 2543-2556 [Abstract] [Full Text]  
  • Patel, P. R., Larson, A. K., Castel, A. D., Ganova-Raeva, L. M., Myers, R. A., Roup, B. J., Farrell, K. P., Edwards, L., Nainan, O., Krick, J. P., Blythe, D., Fiore, A. E., Roche, J. C. (2006). Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies.. JAMA 296: 2005-2011 [Abstract] [Full Text]